Invention Grant
- Patent Title: Compositions and methods for diagnosis and treatment of cancer
-
Application No.: US16972794Application Date: 2019-06-06
-
Publication No.: US11673939B2Publication Date: 2023-06-13
- Inventor: Ugur Sahin , Bonny Gaby Lui , Nadja Salomon , Joycelyn Wüstehube-Lausch , Matin Daneschdar , Hans-Ulrich Schmoldt , Markus Fiedler
- Applicant: BioNTech SE
- Applicant Address: DE Mainz
- Assignee: BioNTech SE
- Current Assignee: BioNTech SE
- Current Assignee Address: DE Mainz
- Agency: McDonnell Boehnen Hulbert & Berghoff LLP
- Priority: WO TEP2018065205 2018.06.08
- International Application: PCT/EP2019/064872 2019.06.06
- International Announcement: WO2019/234190A 2019.12.12
- Date entered country: 2020-12-07
- Main IPC: C07K14/78
- IPC: C07K14/78 ; C07K1/107 ; G01N33/574 ; G01N33/68 ; A61K38/00
Abstract:
The present invention relates to the diagnosis and treatment of diseases expressing Fibronectin Extra Domain B (EDB) such as diseases characterized by tissue remodeling and/or angiogenesis, in particular cancerous diseases, such as head and neck, brain, colorectal, lung, prostate and breast cancer. More particularly, the invention concerns peptides targeting Fibronectin Extra Domain B.
Public/Granted literature
- US20210246191A1 Compositions and Methods for Diagnosis and Treatment of Cancer Public/Granted day:2021-08-12
Information query
